Median Effective Dose of Rocuronium for the Prevention of Myofibrillation Caused by the Injection of Succinylcholine
Clinical trial NCT05909696 · COMPLETED
Trial details
- NCT number
- NCT05909696
- Sponsor
- Yangzhou University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2023-10-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.